The Male Hormone Stack: What Works and What Does Not
Sleep restriction lowers testosterone more than any supplement in this category raises it, which sets the priority order and keeps the stack short.
The Short Answer
The useful comparison in this category is quantitative. Restricting sleep to five hours a night for one week lowered daytime testosterone measurably in young men. Weight loss in men with obesity raises testosterone. No supplement marketed for the purpose approaches either effect. That sets the sequence: measure properly, remove the suppressors, correct genuine shortfalls, and then consider a short list of compounds with modest evidence.
Measure First, and Properly
A stack built without measurement is guessing, and the measurement goes wrong easily.
Total testosterone before 10am, since diurnal variation is large enough to move a result across a threshold. Repeat any abnormal value on a separate morning.
SHBG, without which total testosterone cannot be interpreted. It falls with obesity and insulin resistance and rises with age.
Free testosterone, calculated from total testosterone, SHBG and albumin. Direct immunoassays perform poorly.
LH and FSH, which locate the cause: high with low testosterone means a testicular problem, low or inappropriately normal means a pituitary or hypothalamic one.
Oestradiol by a sensitive assay, since standard assays are unreliable at male concentrations.
Alongside: HbA1c and fasting insulin, thyroid function, ferritin with transferrin saturation, vitamin D, full blood count and prolactin where gonadotropins are low.
The ferritin point is specific: haemochromatosis damages the pituitary and causes secondary hypogonadism, and it is correctable and missed. The panel article covers the technique in detail.
Remove the Suppressors
| Suppressor | Effect size relative to supplements |
|---|---|
| Insufficient sleep | Larger than any supplement effect in this article |
| Excess adiposity | Larger; adipose aromatase converts testosterone to oestradiol |
| Sleep-disordered breathing | Independently associated with low testosterone |
| Energy deficit with high training volume | Suppresses the axis reliably |
| Excess alcohol | Direct testicular effects and altered hepatic metabolism |
| Opioids and glucocorticoids | Suppress the axis directly; often overlooked |
| Chronic overtraining | Distinct from the benefit of appropriate training |
| Prior anabolic steroid use | Can leave a suppressed axis for a prolonged period |
| Very low dietary fat | Associated with lower testosterone; steroid hormones derive from cholesterol |
In most men with low testosterone in midlife, one or more of these is present and is the actual cause. Addressing it is both more effective and more durable than adding a compound, and it is the step most often skipped in favour of a purchase.
The Stack That Has Evidence
Vitamin D, where status is low. Correction in men with low status has shown modest increases in some trials. No effect in replete men, which is the pattern throughout this category.
Zinc, where intake is low. Required for testosterone synthesis. Correction helps where there was a shortfall; supplementation in adequate men does not raise it. Sustained high-dose zinc impairs copper absorption, which is a real rather than theoretical concern.
Magnesium. Some evidence for free testosterone, plausibly through reduced SHBG binding. Modest, and intake is commonly low.
Ashwagandha, 300 to 600 mg standardised. Several small trials report increases in testosterone alongside reduced cortisol and improved stress measures, which suggests it works by removing a suppressor rather than stimulating production. Withanolide content varies widely between products, and there are uncommon case reports of liver injury.
Creatine, 3 to 5 g. Not a hormonal compound and it belongs here, because it supports the training that supports the axis.
Adequate protein and total energy, which is a nutritional rather than supplemental item and matters more than most of the above.
What Does Not Work, and What Is Not a Supplement
Tribulus terrestris. The archetypal ingredient in this category, and it repeatedly fails to raise testosterone in trials.
D-aspartic acid. Initial positive findings were not replicated, and longer trials showed no effect or a decline.
Fenugreek. Mixed and mostly small results.
Proprietary testosterone boosters. Combine several of the above at undisclosed doses. Worse, products in this category have been found to contain undeclared steroids or prohormones, which is a documented adulteration pattern and a reason to prefer third-party tested products or avoid the category.
DHEA and pregnenolone. Precursor hormones rather than supplements, prescription-only in many jurisdictions, converting unpredictably to androgens and oestrogens. Not appropriate for self-directed use.
Aromatase inhibitors and SERMs. Prescription medicines used off-label in some circles. Suppressing oestradiol in men carries bone density and lipid consequences, and oestradiol has necessary functions in men. Not a supplement decision.
Peptide secretagogues. Research chemicals with the sourcing problems that implies.
When It Becomes Clinical
Some situations are not stack problems, and continuing to optimise delays what would help.
Symptomatic, biochemically confirmed hypogonadism on repeat morning measurement, after reversible causes have been addressed. Testosterone therapy is an appropriate clinical option with real benefits and real obligations, including haematocrit and PSA monitoring, and it suppresses spermatogenesis, which matters for anyone who may want children and is frequently under-discussed.
Low testosterone with low gonadotropins, which needs prolactin measurement and may need pituitary imaging.
Raised ferritin with high transferrin saturation, which needs genetic testing for haemochromatosis.
Any visual field change, headache or galactorrhoea, which suggests a pituitary cause.
What to avoid: self-directed testosterone from unregulated sources, which carries dosing, quality and monitoring problems; and stopping abruptly after prolonged use, which leaves a suppressed axis.
The honest framing of this stack: it can correct a shortfall and remove a suppressor, and it cannot override an endocrine axis. Where the axis is genuinely failing, the answer is clinical, and no combination of the compounds above substitutes for it.
A Realistic Sequence
Weeks 1 to 2. Measure, properly, morning, with SHBG and gonadotropins, alongside the metabolic and nutrient panel.
Weeks 1 to 12. Sleep regularity, alcohol reduction, resistance training established, energy intake matched rather than deliberately restricted, and sleep-disordered breathing assessed if suspected. Address adiposity if present, which is slow and is the largest lever.
Week 4. Correct what the panel showed low: vitamin D, zinc, magnesium, iron.
Week 8. Add ashwagandha if stress and sleep are contributors and remain so.
Month 3 to 6. Re-measure, on a morning, under similar conditions.
Month 6. If symptoms persist with confirmed low levels against a well-executed version of the above, that is the clinical conversation rather than a further supplement.
Expect the behavioural and body composition changes to produce most of any improvement, and expect that to take months rather than weeks. That is the shape of this Pillar, and a stack promising otherwise is promising something the endocrine system does not permit.
The AEONNN Perspective
AEONNN's ordering in this stack follows effect size rather than caution. Sleep restriction lowers testosterone more than any of these compounds raises it, and weight loss in men with obesity does more still, so the platform surfaces those first even though a stack recommendation is the more saleable output.
The Quality and Safety layers do unusual work here. Testosterone-boosting products have a documented adulteration pattern with undeclared steroids and prohormones, ashwagandha's withanolide content varies widely between products with uncommon liver injury reports, and sustained high-dose zinc impairs copper absorption. Precursor hormones such as DHEA, and off-label aromatase inhibitors, sit outside what the platform recommends for self-directed use.
Two upstream Pillars usually hold the answer. Pillar 4 adiposity and insulin resistance lower SHBG and total testosterone, and Pillar 9 sleep and sleep-disordered breathing are independently associated with low testosterone. And the platform marks the boundary explicitly: confirmed symptomatic hypogonadism is clinical territory where testosterone therapy carries real benefits and real obligations, fertility suppression among them.
Pillar Matrix mapping
Database Matrix layers
- Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
- Safety Layer (DrugBank, FAERS)
- Quality / Formulation Layer (ConsumerLab, Labdoor)
- Meta / Consensus Layer (JAMA, BMJ, specialty society positions)
Frequently Asked
What raises testosterone most effectively?
Adequate sleep and reducing excess adiposity. Sleep restriction to five hours lowered daytime testosterone measurably in young men, and weight loss in men with obesity raises it more than any supplement.
Which supplements actually help?
Vitamin D, zinc and magnesium where status or intake is low, and ashwagandha where stress is a contributor. All are corrections or suppressor removal rather than enhancement.
Does tribulus work?
No. It is the archetypal ingredient in this category and repeatedly fails to raise testosterone in trials. D-aspartic acid was not replicated and fenugreek results are mixed.
Are testosterone boosters ever adulterated?
Products in this category have been found to contain undeclared steroids or prohormones. It is a documented pattern and a reason to prefer third-party tested products.
Should I take DHEA?
It is a precursor hormone rather than a supplement, prescription-only in many jurisdictions, and converts unpredictably to androgens and oestrogens. It is not appropriate for self-directed use.
What about aromatase inhibitors to lower oestradiol?
Prescription medicines used off-label. Suppressing oestradiol in men carries bone density and lipid consequences, and oestradiol has necessary functions in men. Not a supplement decision.
When is testosterone therapy appropriate?
For symptomatic, biochemically confirmed hypogonadism on repeat morning measurement after reversible causes are addressed. It requires haematocrit and PSA monitoring and it suppresses fertility.
Evidence and review
Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.